Liriodenine is used in research for its potential anticancer properties, particularly in studies involving apoptosis induction in tumor cells such as lung, liver, and breast cancer lines. It shows activity against certain multidrug-resistant cancer lines, making it of interest in oncology drug development. Additionally, it has been investigated for antimicrobial effects, including inhibition of specific bacteria and fungi, and anti-inflammatory properties, with potential applications in health products or cosmetics for reducing skin inflammation. It acts as a natural product scaffold for synthesizing derivatives to enhance bioactivity and selectivity. Currently limited to laboratory and preclinical studies; not used in clinical or industrial applications.